May 22, 2024

UNITED STATES: RQM+, a number one world MedTech contract analysis group (CRO), has introduced the appointment of John Potthoff, Ph.D., as its new CEO. This transition follows Margaret Keegan’s resolution to step again from day-to-day operations to give attention to her position as an working accomplice with Linden Capital Companions, whereas remaining on RQM+’s board.

John Potthoff, co-founder and former CEO of Elligo Well being Analysis, brings intensive experience within the MedTech trade to his new position. With earlier management positions at corporations resembling Theorem Scientific Analysis and INC Analysis, Potthoff is well-equipped to drive RQM+’s development and advance world healthcare by means of MedTech innovation.

– Commercial –

Additionally Learn: RMS Cloud Appoints David Murray as CEO to Lead World Growth Efforts

“Throughout Margaret’s tenure, she accomplished three acquisitions and made important progress in creating an end-to-end MedTech CRO at RQM+,” stated Potthoff. “I sit up for constructing on this exceptional basis and persevering with to drive development and advance world healthcare by means of MedTech innovation.”

– Commercial –

Margaret Keegan expressed her confidence in Potthoff’s management, stating, “I’m extraordinarily happy with the RQM+ group’s many accomplishments. Whereas I’ll be stepping away from day-to-day operations, I sit up for persevering with to assist the corporate. I consider John is a confirmed chief and may be very educated in regards to the firm and our trade. He’s well-positioned to steer and improve RQM+ to satisfy the ever-changing MedTech trade wants now and into the long run.”

Embracing Management Change at RQM+

Potthoff, in a LinkedIn put up, expressed his pleasure about his new position, stating, “Right this moment marks an thrilling change in my profession getting into the position of CEO at RQM+. I’ve served on the RQM+ board since 2021, so not solely do I do know the group and enterprise, but in addition it is a nice match for my expertise rising organizations and with my MedTech trade background.”

– Commercial –

RQM+ stands as a outstanding determine within the MedTech sector, offering a complete vary of providers together with consulting, medical trials, lab operations, reimbursement providers, and expertise options tailor-made to assist the whole lot of the product lifecycle.

Backed by a various world group comprising medical, technical, and trade specialists, RQM+ endeavors to redefine requirements of excellence inside the trade. Their efforts give attention to mitigating commercialization dangers related to medical units, digital therapeutics, and diagnostics, thus fostering innovation in healthcare. Having fun with the belief of main medical gadget producers and in vitro diagnostic (IVD) corporations alike, RQM+ stays steadfast in its dedication to advancing healthcare by means of cutting-edge options and practices.

Additionally Learn: ASML’s New CEO Christophe Fouquet Takes Cost Amidst Geopolitical Tensions

  • Writer, Awards Successful Filmmaker. Protecting voice of individuals, opinions round Expertise and Profession improvement. On the mission to redefine Journalism.

    View all posts